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Background: We examined whether or not peripheral nerves can be regenerated using uncultured adipose-
derived regenerative cells (ADRCs). We also searched humoral factors which might promote proliferation 
or migration of Schwann cells. 
Methods: Thirty rats were randomly assigned to 3 groups. A 10-mm sciatic nerve defect was bridged using 
a silicon tube filled with physiological saline (control group), type I collagen gel (collagen group) and a 
mixture of ADRCs and type I collagen gel (ADRC group). The regenerated tissues were studied 2 weeks 
after surgery.  
Results: Continuity of regenerated tissue was observed in all rats in the control group and the ADRC group. 
In the collagen group, only two rats had a bridge of thin tissue which was barely visible macroscopically. 
Protein gene product 9.5 staining confirmed significantly faster regeneration in the ADRC group. The 
distributions of the PKH-26 positive areas and the S-100 protein positive areas were different, which 
suggests that the transplanted cells had not differentiated into Schwann cells. In real-time RT-PCR, 
neuregulin-1 (Neu-1) and vascular endothelial growth factor A (VEGFA) expression were detected in 
uncultured ADRCs before transplantation. The regenerated tissue in the ADRC group had higher levels of 
Neu-1 and VEGFA expression compared to the control group. 
Conclusions: ADRCs promote peripheral nerve regeneration. The mechanism does not involve 
differentiation of transplanted cells into Schwann cells, but probably involves secretion of some type of 




Microsurgery began to be used to repair nerve injuries in the 1960s. Thereafter the treatment has markedly 
advanced. In 1972, Millesi et al. used autologous sural nerve grafts for median and ulnar nerve repair [1]. 
Subsequently, autologous nerve grafts began to be used that can bridge large peripheral nerve defects 
without tension after trauma or malignant tumor resection. However, autologous nerve grafting has had 
problems such as limitation in the defect size and complaints about the donor site. Therefore, artificial 
nerve conduits have been developed which apply the principles of tubulization [2]. Development has been 
advanced in two aspects: materials filling the tubes and materials making up the tubes. Many reports have 
described the effectiveness of filling the tubes with materials such as nerve growth factors [3-6] and various 
cellular factors [7-9]. The nerve growth factors disappear if they are not continuously infused. Cellular 
factors have not been widely applied clinically due to ethical and technical reasons. In this study, we 
examined whether or not peripheral nerves can be regenerated using adipose-derived regenerative cells 
(ADRCs) [10] which can be easily isolated in large amounts from autologous adipose tissue. ADRCs were 
used as much as possible without culturing or induced differentiation to enable easier future clinical 
application of these cells. Ikeda et al. examined regenerated axons in rats over time [7]. They observed that 
the regenerative ability of axons was high. In addition, they reported that the number of regenerated axons 
did not differ significantly at 8 weeks after transplantation between a group having tubes filled with 
physiological saline alone and a group having tubes filled with Schwann cells. Thus, we evaluated 
regenerated axons which were excised 2 weeks after transplantation to examine early axonal outgrowth. 
Materials and Methods 
Study Design 
 The experiment was conducted with the approval of the Kanazawa University Advanced Science 
Research Center. Thirty 10-week-old Wistar rats were randomly assigned to 3 groups. A 10-mm sciatic 
nerve defect was created in each rat. The following were used to fill a silicon tube (inner diameter: 2 mm, 
wall thickness: 0.5 mm): physiological saline alone for the control group, type I collagen gel alone 
(Cellmatrix Type I-A, Nitta Gelatin, Osaka) for the collagen group, and a mixture of uncultured ADRCs 
and type I collagen gel for the ADRC group. The defect was bridged with the tube. We evaluated 
regenerated tissues which were excised 2 weeks after transplantation. 
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 ADRCs Isolation 
 Isolation of ADRCs was performed by modifying a previously reported method [11]. Adipose 
tissue (1.5 g) was harvested from the left inguinal region of a rat and washed with phosphate-buffered 
saline (PBS, Wako, Osaka). The tissue was cut into strips over a period of 5 minutes. Collagenase 
(Collagenase, Wako) was dissolved in PBS so that its concentration would be 0.12% in 20 ml, and it was 
used to digest adipose tissue at 37oC for 45 minutes in a water bath. The mixture was shaken every 15 
minutes during the digestion period. Immediately after the reaction was completed, 20 ml of Dulbecco’s 
modified Eagle’s medium (D-MEM, Wako) was added and collagenase activity was neutralized. The 
resulting solution was filtered. The filtrate was centrifuged at 1300 rpm for 6 minutes at 25oC, and the 
supernatant was removed. The pellet of ADRCs was subsequently used to fill the tubes. Approximately 1×
106 cells are included in this pellet.  
Surgical Method 
 Surgery was performed in accordance with the “Guide for the Care and Use of Laboratory 
Animals” published by the US National Institute of Health (NIH Publication No. 85-23, Revised 1996) and 
using aseptic techniques. Anesthesia was achieved with 6.5 mg of sodium pentobarbital (Somnopentyl®, 
Intervet, Tokyo) administered intraperitoneally. The right sciatic nerve was exposed and transected at the 
mid-thigh level. The aforementioned silicone tube was used so that it bridged a nerve gap of 10 mm. That is, 
a 12-mm-long tube was filled with one of the previously mentioned materials. The distal and proximal 
stumps were inserted 1 mm into the distal and proximal ends of the tube, respectively. Four stitches of 10-0 
nylon sutures were used to fixate each stump to the tube. In the ADRC group, the pellet of ADRCs was 
disrupted and homogenized in type I collagen gel using a syringe, and surgery was performed on each rat 
using ADRCs from its own adipose tissue. Finally, the gluteus muscles and skin were closed with 6-0 nylon 
sutures, and the surgery was completed. 
Macroscopic Evaluation 
 Macroscopic evaluation was performed on the continuity of regenerated tissue in the tubes. 
Immunohistochemical Evaluation 
 Paraffin sections were prepared containing cross-sections of the central portion of the regenerated 
tissues. The presence of Schwann cells was evaluated by staining for S-100 protein (1:300, Abcam, UK). 
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 Paraffin sections were also prepared containing longitudinal sections of the regenerated tissues. They were 
stained for protein gene product (PGP) 9.5 (1:200, Abcam), and the length of regenerated axons was 
measured from the beginning of the tube to the last visible positive areas. 
PKH-26 Labeling 
 ADRCs were labeled with PKH-26 dye (PKH Linker Kit, SIGMA-ALDRICH, St. Louis) and 
transplanted. PKH-26 binds to the cell membrane and has stability for more than 100 days which enables 
the tracing of PKH-26 labeled transplanted cells in host tissue. Two weeks later, a frozen section was 
prepared containing a cross-section of the central portion of the regenerated tissue, and the survival of the 
transplanted cells was examined. The same section was stained for S-100 protein. Comparison was made 
between the PKH-26 positive areas and the S-100 protein positive areas, and examination was performed to 
determine whether or not the transplanted cells differentiated into Schwann cells. 
Analysis of mRNA Expression 
 Real-time RT-PCR was performed on pre-transplant ADRCs and regenerated tissues two weeks 
after transplantation using the following methods. The expression of neuregulin-1 (Neu-1) and vascular 
endothelial growth factor A (VEGFA) were analyzed.  
1. Total mRNA Isolation 
 RNA was extracted using a NucleoSpin® RNA II kit (TAKARA BIO, Otsu, Japan). Each sample 
was disrupted and homogenized using a syringe. Thereafter, treatment was performed according to the 
manufacturer’s protocol. The absorbance of the resulting total RNA was measured at 260 nm, and the 
concentration was calculated. 
2. cDNA Synthesis 
cDNA was synthesized using the High Capacity RNA-to-cDNA Master Mix® (Applied 
Biosystems, CA). Treatment was performed according to the manufacturer’s protocol, and adjustments 
were made to yield a total volume of 20 µl. Then the following conditions were used on a GeneAmp® PCR 
System 9700 (Applied Biosystems) to synthesize cDNA: 25°C for 5 minutes, 42°C for 30 minutes, 85°C 
for 5 minutes and a 4°C hold. 
3. Real-Time RT-PCR 
To 1µl of the resulting cDNA sample, 5µl of TaqMan® Universal Master Mix II (Applied 
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 Biosystems), 0.5 µl of primer, and 3.5 µl of RNAse free water (Applied Biosystems) were added. The total 
volume was 10 µl. Primers of rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Neu-1, and 
VEGFA were purchased from Applied Biosystems. Reactions were performed using an ABI PRISM 7700 
Sequence Detection System (Applied Biosystems) with cycles 50°C for 2 minutes, 95°C for 10 minutes, 
95°C for 15 seconds, and 60°C for 1 minute, and amplification was performed 40 times. The expression 
ratios of Neu-1 to GAPDH and VEGFA to GAPDH were calculated for each sample. 
Statistical Analysis 
Experimental results were expressed as means±SD and were analyzed using a t-test. The 
differences were considered significant when p<0.05. 
Results 
Macroscopic Evaluation 
 Continuity of regenerated tissue was observed in all rats in the control group and the ADRC group. 
The gap was bridged by blood clot-like tissue in all rats in the control group (Fig. 1A). Most areas were 
occupied by white tissue in the ADRC group (Fig. 1B). In the collagen group, only two rats had a bridge of 
thin tissue which was barely visible macroscopically. Ikeda et al. have reported that regenerated axons 
could not invade into type I collagen gel alone at 2 weeks owing to lack of migration of Schwann cells [7], 
and our results are compatible with this report. Therefore, we excluded the collagen group from the 
following assessment. 
Immunohistochemical Evaluation 
1. Staining for S-100 Protein 
 There were no areas positive for S-100 protein in the control group (Fig. 2A), and Schwann cells 
had not migrated to the central portion of the regenerated tissue. Schwann cells were observed in only the 
ADRC group (Fig. 2B). 
2. Staining for PGP 9.5 Protein 
The lengths of the regenerated tissues were compared between the control group (Fig. 3A) and the 
ADRC group (Fig. 3B). The ADRC group had significantly more axonal regeneration compared to the 




  The PKH-26 positive areas (red) are shown in Fig. 5. It reveals that transplanted cells had survived 
two weeks after transplantation. The same section was used to stain for S-100 protein (green). The 
distributions of the PKH-26 positive areas and the S-100 protein positive areas were different. This finding 
suggests that the transplanted cells had not differentiated into Schwann cells 2 weeks after transplantation. 
Real-time RT-PCR 
 Neu-1 and VEGFA expression were detected in the pre-transplant ADRCs. Neu-1 and VEGFA 
expression were detected in the regenerated tissue in the control group and the ADRC group. The 
regenerated tissue in the ADRC group had significantly higher levels of Neu-1 and VEGFA expression 
compared to uncultured ADRCs before transplantation (Fig. 6A). The ADRC group had significantly higher 
levels of Neu-1 and VEGFA expression compared to the control group (Fig. 6B). 
Discussion 
 Regenerative medicine using stem cells is a field that has gained great interest. Stem cells can be 
divided broadly into pluripotent stem cells and somatic stem cells. Pluripotent stem cells have the ability to 
differentiate into all types of cells and include embryonic stem (ES) cells [12] and induced pluripotent stem 
(iPS) cells [13]. Somatic stem cells have the ability to differentiate into only certain types of cells. 
Pluripotent stem cells have a high ability to differentiate. However, they have risks of neoplastic 
transformation and their use raises ethical and technical issues. Somatic stem cells have a lower ability to 
differentiate compared with pluripotent stem cells. However, somatic stem cells have a higher safety profile 
and early clinical application might be possible. 
 In recent years, it has been shown that somatic stem cells exist in adipose tissue [11], and these 
cells began to be called “adipose-derived stem cells” (ADSCs). An in vitro study revealed that ADSCs have 
the ability to differentiate into the following cells, just like bone marrow-derived stem cells (BMSCs): 
osteoblasts, chondrocytes, neurons, and cells other than germ cells (e.g., stem cells) [14]. Multiple reports 
have already been published regarding clinical applications of ADSCs including in breast reconstruction 
and breast augmentation [15, 16]. There are also reports of their use to treat ischemic heart disease, tracheal 
fistula [17], intestinal fistula associated with Crohn’s disease [18], and GVHD [19, 20]. The reason why 
ADSCs are used now is that autologous ADSCs can be easily isolated in large amounts from subcutaneous 
adipose tissue. In addition, ADSCs can be harvested less invasively compared to BMSCs, and many more 
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 stem cells can be harvested at one time [21, 22]. In clinical applications, autologous ADSCs should be used, 
if possible, from the perspective of safety, and ADSCs should be minimally manipulated. For the above 
reasons, we have focused on ADSCs as a new source of tissue stem cells, replacing bone marrow. 
 Several reports have been published regarding peripheral nerve regeneration using ADSCs, but 
most reports involved culturing or induced differentiation [23-25]. We proposed that clinical application of 
peripheral nerve regeneration can become closer to reality with the use of uncultured ADRCs. ADRCs 
contain ADSCs, vessel-forming cells, such as endothelial and smooth muscle cells and progenitors, and 
preadipocytes [10]. The result of our present study showed that ADRCs promote peripheral nerve 
regeneration. The distributions of the PKH-26 positive areas and the S-100 protein positive areas were 
different. This result suggests that the mechanism does not involve differentiation of ADSCs among 
ADRCs into Schwann cells but involves secretion of some type of humoral factor by ADRCs, promoting 
proliferation or migration of Schwann cells. It would be ideal for ADSCs among ADRCs to differentiate 
into Schwann cells. However, it might be necessary to have a certain amount of mature cells in the target 
tissue to induce differentiation of stem cells. Then, we examined what types of humoral factors might 
promote proliferation or migration of Schwann cells. Various extracellular stimulation and conditions 
promote cell proliferation. In particular, axon-derived Neu-1 very strongly promotes Schwann cell 
proliferation [26]. The mechanism is known to involve the activation of the intracellular MEK pathway and 
the phosphatidylinositol-3-kinase pathway [27]. In our study, the results of real-time RT-PCR suggest that 
ADRCs probably secrete Neu-1, and the relationship between ADRCs and Neu-1 has not been reported yet. 
VEGFA, on the other hand, has been reported to act directly on not only vascular endothelial cells but also 
Schwann cells, neurons, and neural stem cells, drawing attention to a close relationship between blood 
vessels and nerves [28]. In particular, VEGFA has been reported to stimulate Schwann cell proliferation and 
migration [29, 30].  Therefore, these results suggest that ADRCs promote peripheral nerve regeneration by 
probably secreting humoral factors such as Neu-1 and VEGFA and by involving in various stages of 
Schwann cells including proliferation and migration. These findings are consistent with our result that the 
ADRC group had significantly increased expression of Neu-1 and VEGFA in the regenerated tissue 
compared to the control group. Perhaps when ADRCs are transplanted near a nerve stump, they change into 
cells that actively secrete Neu-1 and VEGF even though these cells might not differentiate into Schwann 
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 cells (Fig. 7A). ADRCs possibly regulate nerve stumps to promote secretion of such factors (Fig. 7B), or 
besement membrane from various cells in ADRCs may be favorable for axonal regeneration. Future studies 
are needed to examine this speculation. The results of our study suggest that ADRCs might play a very 
important role as a future tool for peripheral nerve regeneration. It will be necessary to make the longer 
period model for future clinical applications. 
Conclusions 
ADRCs promote peripheral nerve regeneration. The mechanism does not involve differentiation of ADSCs 
among ADRCs into Schwann cells, but probably involves secretion of some type of humoral factor such as 
Neu-1 or VEGFA, promoting proliferation or migration of Schwann cells. 
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 Figure captions 
Figure 1 Macroscopic Findings 
The gap was bridged by blood clot-like tissue in all rats in the control group (A), while most areas were 
occupied by white tissue in the ADRC group (B). 
 
Figure 2 Staining for S-100 Protein (×40) 
Paraffin sections were prepared containing cross-sections of the central portion of the regenerated tissues. 
The presence of Schwann cells was evaluated by staining for S-100 protein. (green: S-100, blue: DAPI) 
A. Control group 
B. ADRC group 
 
Figure 3 Staining for protein gene product (PGP) 9.5 Protein 
Paraffin sections were prepared containing longitudinal sections of the regenerated tissues. They were 
stained for PGP 9.5 (green), and axonal regeneration was quantitatively evaluated. 
A. Control group 
B. ADRC group 
 
Figure 4 
The lengths of the regenerated tissues were compared between the control group and the ADRC group. The 
ADRC group had significantly more axonal regeneration compared to the control group (p=0.0043). 
 
Figure 5 PKH-26 Labeling (×40) 
ADRCs were labeled with PKH-26 dye. Two weeks later, frozen sections were prepared containing cross-
sections of the central portion of the regenerated tissues. The PKH-26 positive areas (red) were different 
from S-100 positive areas (green). 
 
Figure 6. Real-time RT-PCR 
A. Comparison between uncultured ADRCs and regenerated tissue (black bar: ADRCs, gray bar: 
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 regenerated tissue) 
The regenerated tissue in the ADRC group had higher levels of Neu-1 and VEGFA expression compared to 
the uncultured ADRCs before transplantation (A). 
B. Comparison between control group and ADRC group (black bar: control group, gray bar: ADRC group) 
The regenerated tissue in the ADRC group had higher levels of Neu-1 and VEGFA expression compared to 
the control group (B). 
 
Figure 7 Mechanism of peripheral nerve regeneration using uncultured ADRCs 
A. ADRCs can change into cells that actively secrete Neu-1 and VEGF even though these cells might not 
differentiate into Schwann cells. 
B. ADRCs can regulate nerve stumps to promote secretion of humoral factors. 
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